Barbara E Montana, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-923-6540 Fax: 732-923-6536 |
Pavan Kumar Yalamanchili, Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 |
Dr. Rajagopalan Sivaprasad, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-842-5272 Fax: 732-244-1005 |
Masako Mizusawa, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 |
Mrs. Yuliya Nudelman, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 |
News Archive
Acculis Limited today announced the regulatory clearance of its revolutionary new device for destroying unwanted tissues, such as liver tumours. The clearance under the European CE Mark system allows the company to begin deliveries for treating patients throughout Europe and elsewhere where the CE Mark system is recognised. The device is a single high power high frequency 2.45GHz microwave needle that burns a 5cm sphere of tissue in just 5 minutes which is between 3 to 10 times faster than old school radiofrequency based systems or lower frequency 915MHz microwave systems.
In a study published online this week and to be published as a cover story in the July issue of Nature Genetics, Rosetta Genomics' scientists report identification of hundreds of human microRNA genes, including the first report of primate specific microRNAs.
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have created a gut-on-a-chip microdevice lined by living human cells that mimics the structure, physiology, and mechanics of the human intestine-even supporting the growth of living microbes within its luminal space.
The first Esteya electronic brachytherapy system in the United States has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer treatment that relies on a small, high dose rate (HDR) X-ray source to apply high precision radiotherapy directly to the cancer site.
› Verified 4 days ago